We are live on
!
Find out more
RC
RBO & Co Portfolio holdings
AUM
$620M
1-Year Est. Return
4.67%
This Fund
S&P 500
This Quarter
Est. Return
+3.63%
1 Year Est. Return
+4.67%
3 Year Est. Return
+29.1%
5 Year Est. Return
+42.82%
10 Year Est. Return
+156.53%
AUM
$370M
AUM Growth
+$13.7M
(+3.8%)
Cap. Flow
+$410K
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
43.49%
Holding
50
New
1
Increased
10
Reduced
30
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$5.9M |
| 2 |
Coca-Cola
KO
|
+$4.11M |
| 3 |
AT&T
T
|
+$160K |
| 4 |
Chevron
CVX
|
+$68.9K |
| 5 |
AbbVie
ABBV
|
+$65K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.61M |
| 2 |
Labcorp
LH
|
+$1.74M |
| 3 |
RWT
Redwood Trust
RWT
|
+$1.14M |
| 4 |
Lumen
LUMN
|
+$1.07M |
| 5 |
Graco
GGG
|
+$774K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Staples | 23.94% |
| 2 | Healthcare | 17.47% |
| 3 | Financials | 14.1% |
| 4 | Consumer Discretionary | 8.36% |
| 5 | Industrials | 6.33% |
Similar funds
TTSTC
KFAS
RIS
AMG
BWP
MC
ACP
ACM
RBO & Co's Q2 2017 Portfolio in Review
As of Q2 2017, RBO & Co held 50 positions worth $370M, up 3.8% from $357M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Trading was light in Q2 2017: portfolio turnover was 2%. RBO & Co opened 1 new position and made no exits, leaving the 50-position portfolio largely intact.
By sector, the portfolio is most concentrated in Consumer Staples at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- RBO & Co's largest Q2 2017 buy was Zoetis: 99,970 shares worth $6.24M.
- RBO & Co added most to Coca-Cola in Q2 2017, an estimated $4.11M increase.
- RBO & Co's biggest Q2 2017 reduction was Apple, cutting an estimated $3.61M.
- RBO & Co's ten largest holdings make up 43% of its $370M portfolio in Q2 2017.
- RBO & Co opened 1 new position and closed 0 in Q2 2017.
- RBO & Co's portfolio value rose 3.8% quarter-over-quarter to $370M.
Based on RBO & Co's 13F filing for Q2 2017, filed 8 Aug 2017.